Researcher.Life Logo

Future Medicinal Chemistry : Impact Factor & More

eISSN: 1756-8927pISSN: 1756-8919

Key Metrics

CiteScore
6.1
Eigenfactor
0.005 - 0.01
H-Index
84
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.83
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Future Medicinal Chemistry

Future Medicinal Chemistry Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher NEWLANDS PRESS LTD
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year2009
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Future Medicinal Chemistry ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Future Medicinal Chemistry

New chromene derivatives as promising VEGFR-2 inhibitors: combined experimental, DFT, and molecular dynamics approaches.
  • 19 May 2026
  • Future medicinal chemistry
Ultrasound-assisted 1,2,4-triazole Schiff bases: synthesis, characterization, docking, and dual inhibition of urease and α-glucosidase.
  • 19 May 2026
  • Future medicinal chemistry
Targeting traumatic brain injury via novel tetrahydrocarbazole derivatives: in silico design, synthesis, and in vitro evaluation of dual NADPH oxidase 2 and 4 inhibitors.
  • 14 May 2026
  • Future medicinal chemistry
Tailored pyrazolone-oxadiazole frameworks: synthetic execution, functional enzyme studies, and comprehensive docking-DFT-based antidiabetic investigation.
  • 11 May 2026
  • Future medicinal chemistry
Synthesis of 2, 4-disubstituted-1H-benzo[b][1,4]diazepine derivatives as promising anticancer agents.
  • 9 May 2026
  • Future medicinal chemistry
Design, synthesis, and biological evaluation of novel coumarine-1,2,3-triazole hybrids as dual DNA gyrase/superoxide dismutase inhibitors: molecular docking, DFT, and ADMET investigations.
  • 6 May 2026
  • Future medicinal chemistry
New chromene derivatives as promising VEGFR-2 inhibitors: combined experimental, DFT, and molecular dynamics approaches.
  • 19 May 2026
  • Future medicinal chemistry
Ultrasound-assisted 1,2,4-triazole Schiff bases: synthesis, characterization, docking, and dual inhibition of urease and α-glucosidase.
  • 19 May 2026
  • Future medicinal chemistry
Targeting traumatic brain injury via novel tetrahydrocarbazole derivatives: in silico design, synthesis, and in vitro evaluation of dual NADPH oxidase 2 and 4 inhibitors.
  • 14 May 2026
  • Future medicinal chemistry
Tailored pyrazolone-oxadiazole frameworks: synthetic execution, functional enzyme studies, and comprehensive docking-DFT-based antidiabetic investigation.
  • 11 May 2026
  • Future medicinal chemistry
Synthesis of 2, 4-disubstituted-1H-benzo[b][1,4]diazepine derivatives as promising anticancer agents.
  • 9 May 2026
  • Future medicinal chemistry
Design, synthesis, and biological evaluation of novel coumarine-1,2,3-triazole hybrids as dual DNA gyrase/superoxide dismutase inhibitors: molecular docking, DFT, and ADMET investigations.
  • 6 May 2026
  • Future medicinal chemistry

FAQs on Future Medicinal Chemistry